Pfizer and Moderna created life-saving vaccines. So why are their stocks crumbling?
By Paul R. La Monica, CNN Business Pfizer, BioNTech and Moderna are experiencing a post-vaccine hangover on Wall Street this year. All three stocks surged spectacularly in 2021, thanks largely to their Covid-19 vaccines’ success and strong sales. But 2022 hasn’t been as kind to them. Shares of Pfizer are down about 15%, while its
Continue Reading